Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 12 studies | 35% ± 11% | |
endothelial cell | 10 studies | 27% ± 9% | |
glutamatergic neuron | 8 studies | 37% ± 25% | |
endothelial cell of lymphatic vessel | 6 studies | 39% ± 12% | |
basal cell | 5 studies | 36% ± 23% | |
cardiac muscle cell | 4 studies | 24% ± 1% | |
GABAergic neuron | 4 studies | 44% ± 15% | |
neuron | 3 studies | 29% ± 14% | |
epithelial cell | 3 studies | 31% ± 15% | |
hepatocyte | 3 studies | 35% ± 11% | |
oligodendrocyte precursor cell | 3 studies | 22% ± 4% | |
astrocyte | 3 studies | 25% ± 9% | |
interneuron | 3 studies | 38% ± 19% | |
myoepithelial cell | 3 studies | 44% ± 23% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 33% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2141.26 | 1445 / 1445 | 100% | 13.58 | 183 / 183 |
bladder | 100% | 2497.67 | 21 / 21 | 99% | 8.98 | 497 / 504 |
breast | 100% | 2343.25 | 459 / 459 | 98% | 7.51 | 1094 / 1118 |
uterus | 100% | 4430.06 | 170 / 170 | 96% | 9.02 | 440 / 459 |
prostate | 100% | 2709.48 | 245 / 245 | 96% | 5.81 | 481 / 502 |
intestine | 100% | 1139.91 | 963 / 966 | 95% | 4.65 | 499 / 527 |
lung | 100% | 1968.93 | 577 / 578 | 94% | 8.18 | 1090 / 1155 |
brain | 98% | 1685.50 | 2600 / 2642 | 94% | 5.37 | 663 / 705 |
skin | 100% | 2344.48 | 1809 / 1809 | 90% | 4.57 | 427 / 472 |
stomach | 94% | 725.27 | 338 / 359 | 96% | 5.26 | 274 / 286 |
pancreas | 99% | 880.01 | 324 / 328 | 90% | 4.33 | 160 / 178 |
kidney | 99% | 1136.22 | 88 / 89 | 87% | 4.74 | 784 / 901 |
liver | 100% | 937.77 | 226 / 226 | 78% | 3.27 | 316 / 406 |
thymus | 100% | 1135.40 | 652 / 653 | 78% | 3.02 | 470 / 605 |
ovary | 99% | 754.37 | 178 / 180 | 75% | 3.33 | 321 / 430 |
adrenal gland | 100% | 923.78 | 257 / 258 | 73% | 3.21 | 169 / 230 |
adipose | 100% | 1724.17 | 1204 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.59 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.89 | 1 / 1 |
muscle | 100% | 1757.44 | 800 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 1076.53 | 1275 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 1879.72 | 820 / 861 | 0% | 0 | 0 / 0 |
spleen | 95% | 570.21 | 228 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 63% | 2.35 | 50 / 80 |
lymph node | 0% | 0 | 0 / 0 | 59% | 1.86 | 17 / 29 |
peripheral blood | 24% | 185.22 | 224 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006508 | Biological process | proteolysis |
GO_0005634 | Cellular component | nucleus |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
Gene name | USP31 |
Protein name | Ubiquitin specific peptidase 31 Ubiquitin carboxyl-terminal hydrolase 31 (EC 3.4.19.12) (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31) |
Synonyms | KIAA1203 |
Description | FUNCTION: May recognize and hydrolyze the peptide bond at the C-terminal Gly of ubiquitin. Involved in the processing of poly-ubiquitin precursors as well as that of ubiquitinated proteins (By similarity). . |
Accessions | ENST00000563525.2 ENST00000567975.1 A0A087WXV9 Q70CQ4 ENST00000219689.12 [Q70CQ4-1] I3L4X5 |